What is it about?
After investigation of the files of pemphigus patients who received rituximab in Razi Hospital, Tehran, Iran, from 2008 to 2013, 39 patients were entered into the author’s previously unpublished study. The author’s major objective was to gauge the effect of rituximab on laboratory indices of pemphigus vulgaris patients.
Featured Image
Read the Original
This page is a summary of: Research Objectives and Hypotheses, November 2017, Springer Science + Business Media,
DOI: 10.1007/978-3-319-67759-0_17.
You can read the full text:
Contributors
The following have contributed to this page
